Life Sciences


How Halsa Global Unified Clinical and Commercial Operations for a Fast-Growing Pharma 



Halsa Global unified clinical and commercial operations on Salesforce Life Sciences Cloud, enabling AI-driven workflows that accelerated trial recruitment, improved patient adherence, and enhanced medical team productivity.

Agentforce, Data Cloud, Salesforce Life Sciences Cloud

Overview

A fast-growing regional pharmaceutical manufacturer, operating across 20+ states and managing a portfolio of 15 active clinical trials, struggled with fragmented data across its clinical, commercial, and patient services. This fragmentation led to manual processes, compliance risks, and delayed trial recruitment. Halsa Global was engaged to implement a unified, AI-driven platform that could connect siloed systems and enable proactive, data-driven decision-making across their highly regulated environment. 

The Challenge

As the organization expanded, disconnected systems severely limited their operational speed and patient impact: 

  • Fragmented Data and Delayed Trial Recruitment: Disconnected systems across clinical trials, HCP engagements, and patient services caused severe manual bottlenecks, compliance risks, and significant delays in trial recruitment. 
  • Overwhelmed Medical Teams: Repetitive HCP inquiries consistently overwhelmed medical teams, pulling focus away from high-value scientific exchange.
  • Reactive Patient Support and Analytics: Siloed systems hindered the ability to provide personalized patient support and blocked the real-time analytics required for proactive commercial operations. 

Our Solution

Halsa Global implemented Salesforce Life Sciences Cloud, unifying clinical, commercial, and patient data on a compliant platform with Agentforce AI for automated workflows. Key features included AI-powered HCP engagement prep, patient enrollment agents, and medical inquiry management with audit trails. Integrations with Data Cloud provided 360° views of HCPs and patients, enabling next-best actions and consent management. 

The Outcome

  • 50% faster clinical trial recruitment through AI-driven participant matching. 
  • 40% reduction in manual HCP inquiry handling, boosting medical team productivity. 
  • 35% improvement in patient adherence via proactive alerts and unified profiles. 

Conclusion

Through its partnership with Halsa Global, the manufacturer transitioned from fragmented, reactive operations to a unified, AI-powered ecosystem. By connecting clinical, commercial, and patient data on Salesforce Life Sciences Cloud, the organization gained the automated workflows needed to accelerate trial recruitment, boost medical team productivity, and measurably improve patient adherence. 

Scroll to Top